SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 32.50 |
| Enterprise Value ($M) | 30.78 |
| Book Value ($M) | -17.55 |
| Book Value / Share | -4.43 |
| Price / Book | -1.85 |
| NCAV ($M) | -18.35 |
| NCAV / Share | -4.63 |
| Price / NCAV | -1.77 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -3.03 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.89 |
| Current Ratio | 0.89 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.58 |
| Assets | 7.37 |
| Liabilities | 24.93 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Gkcc, Llc | 11.79 | ||
| 13D | Armen Garo H | 9.68 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 5,337 | 10,743 | 49.68 | |
| 7,323 | 11,318 | 64.70 | |
| 3,466 | 12,070 | 28.72 | |
| 638 | 2,243 | 28.44 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMTX – Immatics N.V. | INAB – IN8bio, Inc. |
| INDP – Indaptus Therapeutics, Inc. | INM – InMed Pharmaceuticals Inc. |
| INMB – INmune Bio, Inc. |
Financial data and stock pages provided by
Fintel.io